Is a complete ARDT research report available?

No complete published report is available for Ardent Health, Inc. (ARDT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Ardent Health, Inc. (ARDT)

NYSE: ARDT · USD

$11.9

+0.03 (+0.3%)· Recorded snapshot

Market cap	1.7B
Revenue (ttm)	6.4B
Net income (ttm)	78.2M
EPS (ttm)	$0.55
Shares out	141M
P/E (trailing)	21.5x
P/E (forward)	10.4x
Volume	306,878
Beta	0.72

Market data

Price

Recent price action with selectable time range.

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	نگه‌داری

Metric	Value
Amount currency	USD
CIK code	0001756655
Company name	Ardent Health, Inc.
Country	United States
Country code	US
CUSIP number	03980N107
Earnings date	2026-11-04
Earnings time	amc
Employees	25,200
Employees change	300
Employees growth	1.2%
Enterprise value	$3.2B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2001
In index	RUSSELL2000
Industry	Medical Care Facilities
IPO date	2024-07-18
Is primary listing	Yes
Is SPAC	No
ISIN number	US03980N1072
Last 10-K release date	2026-03-16
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$1.7B
Market cap category	Small-Cap
Next earnings date	2026-11-04
Options	Yes
Price	$11.86
Price currency	USD
Sector	Healthcare
SIC code	8062
Stock price date	2026-10-28
Symbol	ARDT
U.S. state	Tennessee
Website	https://www.ardenthealth.com

Metric

Value

Amount currency

USD

CIK code

0001756655

Company name

Ardent Health, Inc.

Country

United States

Country code

CUSIP number

03980N107

Earnings date

2026-11-04

Earnings time

amc

Employees

25,200

Employees change

300

Employees growth

1.2%

Enterprise value

$3.2B

Exchange

NYSE

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2001

In index

RUSSELL2000

Industry

Medical Care Facilities

IPO date

2024-07-18

Is primary listing

Yes

Is SPAC

ISIN number

US03980N1072

Last 10-K release date

2026-03-16

Last earnings date

2026-08-04

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$1.7B

Market cap category

Small-Cap

Next earnings date

2026-11-04

Options

Yes

Price

$11.86

Price currency

USD

Sector

Healthcare

SIC code

8062

Stock price date

2026-10-28

Symbol

ARDT

U.S. state

Tennessee

Website

https://www.ardenthealth.com

Metric	Value
Adjusted P/E ratio	6.7x
Average P/E ratio (3Y)	12.78x
Earnings yield	4.66%
EV/Earnings	41.27x
EV/EBIT	12.52x
EV/EBITDA	7.64x
EV/FCF	10.59x
EV/Sales	0.5x
FCF / EV yield	9.44%
FCF yield	18.08%
Forward EV/Sales	0.49x
Forward P/E	10.35x
Forward P/S	0.26x
Graham number	10.87317
Graham upside	-9.01%
Industry forward P/E	14.95x
Industry P/E	18.37x
Lynch fair value	$2.76
Lynch upside	-76.9%
P/(FCF - SBC) ratio	6.26x
P/(OCF - SBC) ratio	3.52x
P/B ratio	1.24x
P/E ratio	21.48x
P/FCF ratio	5.53x
P/OCF ratio	3.28x
P/S ratio	0.26x
PEG ratio	2.77x
Price / tangible book value	4.39x
Price/EBITDA ratio	3.99x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Adjusted P/E ratio

6.7x

Average P/E ratio (3Y)

12.78x

Earnings yield

4.66%

EV/Earnings

41.27x

EV/EBIT

12.52x

EV/EBITDA

7.64x

EV/FCF

10.59x

EV/Sales

0.5x

FCF / EV yield

9.44%

FCF yield

18.08%

Forward EV/Sales

0.49x

Forward P/E

10.35x

Forward P/S

0.26x

Graham number

10.87317

Graham upside

-9.01%

Industry forward P/E

14.95x

Industry P/E

18.37x

Lynch fair value

$2.76

Lynch upside

-76.9%

P/(FCF - SBC) ratio

6.26x

P/(OCF - SBC) ratio

3.52x

P/B ratio

1.24x

P/E ratio

21.48x

P/FCF ratio

5.53x

P/OCF ratio

3.28x

P/S ratio

0.26x

PEG ratio

2.77x

Price / tangible book value

4.39x

Price/EBITDA ratio

3.99x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
EBIT margin	4.03%
EBITDA margin	6.59%
Effective tax rate	18.91%
FCF margin	4.76%
Gross margin	58.38%
Operating margin	4.03%
Pretax margin	3.25%
Profit margin	1.22%
Profit per employee	$3,104
Profitable quarters	3
Profitable years	5
Revenue per employee	$254,204
ROA	3.13%
ROCE	5.99%
ROE	9.96%
ROIC	6.25%
SBC / revenue	0.56%
Tax / revenue	0.61%

Metric

Value

EBIT margin

4.03%

EBITDA margin

6.59%

Effective tax rate

18.91%

FCF margin

4.76%

Gross margin

58.38%

Operating margin

4.03%

Pretax margin

3.25%

Profit margin

1.22%

Profit per employee

$3,104

Profitable quarters

Profitable years

Revenue per employee

$254,204

ROA

3.13%

ROCE

5.99%

ROE

9.96%

ROIC

6.25%

SBC / revenue

0.56%

Tax / revenue

0.61%

Metric	Value
EPS growth	-69.6%
EPS growth (Q)	-77.05%
EPS growth (QoQ)	-57.4%
EPS growth years	0
FCF growth	181.84%
FCF growth (Q)	121.7%
FCF growth 3Y	237.8%
FCF growth 5Y	81.74%
Gross profit growth	4.47%
Gross profit growth (Q)	-2.83%
Gross profit growth 3Y	13.23%
Gross profit growth 5Y	30.16%
Net income growth	-69.31%
Net income growth (Q)	-76.84%
Net income growth (QoQ)	-57.59%
Net income growth 3Y	-20.26%
Net income growth years	0
OCF growth	70.32%
OCF growth (Q)	67.45%
OCF growth 3Y	51.84%
OCF growth 5Y	46.89%
Operating income growth	-40.35%
Operating income growth (Q)	-59.37%
Operating income growth 3Y	-5.25%
Operating income growth 5Y	14.24%
Revenue growth	3.35%
Revenue growth (Q)	-1.4%
Revenue growth (QoQ)	1.27%
Revenue growth 3Y	9.57%
Revenue growth 5Y	33.52%
Revenue growth years	4

Metric

Value

EPS growth

-69.6%

EPS growth (Q)

-77.05%

EPS growth (QoQ)

-57.4%

EPS growth years

FCF growth

181.84%

FCF growth (Q)

121.7%

FCF growth 3Y

237.8%

FCF growth 5Y

81.74%

Gross profit growth

4.47%

Gross profit growth (Q)

-2.83%

Gross profit growth 3Y

13.23%

Gross profit growth 5Y

30.16%

Net income growth

-69.31%

Net income growth (Q)

-76.84%

Net income growth (QoQ)

-57.59%

Net income growth 3Y

-20.26%

Net income growth years

OCF growth

70.32%

OCF growth (Q)

67.45%

OCF growth 3Y

51.84%

OCF growth 5Y

46.89%

Operating income growth

-40.35%

Operating income growth (Q)

-59.37%

Operating income growth 3Y

-5.25%

Operating income growth 5Y

14.24%

Revenue growth

3.35%

Revenue growth (Q)

-1.4%

Revenue growth (QoQ)

1.27%

Revenue growth 3Y

9.57%

Revenue growth 5Y

33.52%

Revenue growth years

Metric	Value
Capital expenditures	$-209.6M
Depreciation and amortization	$164.5M
EBIT	$257.9M
EBITDA	$422.4M
EPS	$0.55
FCF per share	$2.16
Financing cash flow	$-118.5M
Free cash flow	$304.8M
Free cash flow minus SBC	$269.1M
Gross profit	$3.7B
Income taxes	$39.3M
Investing cash flow	$-211.9M
Net borrowing	$-7.1M
Net cash flow	$183.8M
Net income	$78.2M
Operating cash flow minus SBC	$478.7M
Operating income	$257.9M
Revenue	$6.4B
Stock-based compensation	$35.7M

Metric

Value

Capital expenditures

$-209.6M

Depreciation and amortization

$164.5M

EBIT

$257.9M

EBITDA

$422.4M

EPS

$0.55

FCF per share

$2.16

Financing cash flow

$-118.5M

Free cash flow

$304.8M

Free cash flow minus SBC

$269.1M

Gross profit

$3.7B

Income taxes

$39.3M

Investing cash flow

$-211.9M

Net borrowing

$-7.1M

Net cash flow

$183.8M

Net income

$78.2M

Operating cash flow minus SBC

$478.7M

Operating income

$257.9M

Revenue

$6.4B

Stock-based compensation

$35.7M

Metric	Value
Altman Z-Score	2.03
Book value per share	$9.52
Debt / EBITDA	3.31
Debt / equity	1.3
Debt / FCF	7.44
Goodwill	$879.3M
Interest coverage	5.05
Long-term assets	$3.2B
Long-term liabilities	$2.6B
Net cash (debt)	$-1.5B
Net cash / market cap	-91.53%
Net debt / EBITDA	3.65
Net debt / equity	0.89
Net debt / FCF	5.06
Piotroski F-Score	6
Property, plant and equipment	$2.1B
Shareholders' equity	$1.7B
Tangible book value	$383.6M
Tangible book value per share	$2.70
Total assets	$5.3B
Total cash	$724.5M
Total debt	$2.3B
Total liabilities	$3.5B
WACC	4.54%

Metric

Value

Altman Z-Score

2.03

Book value per share

$9.52

Debt / EBITDA

3.31

Debt / equity

1.3

Debt / FCF

7.44

Goodwill

$879.3M

Interest coverage

5.05

Long-term assets

$3.2B

Long-term liabilities

$2.6B

Net cash (debt)

$-1.5B

Net cash / market cap

-91.53%

Net debt / EBITDA

3.65

Net debt / equity

0.89

Net debt / FCF

5.06

Piotroski F-Score

Property, plant and equipment

$2.1B

Shareholders' equity

$1.7B

Tangible book value

$383.6M

Tangible book value per share

$2.70

Total assets

$5.3B

Total cash

$724.5M

Total debt

$2.3B

Total liabilities

$3.5B

WACC

4.54%

Metric	Value
Asset turnover	1.24
Current assets	$2.1B
Current liabilities	$976.3M
Current ratio	2.1
Inventory turnover	22.74
Net working capital	$382.8M
Quick ratio	1.49
Working capital	$1.1B
Working capital turnover	6.18

Metric

Value

Asset turnover

1.24

Current assets

$2.1B

Current liabilities

$976.3M

Current ratio

2.1

Inventory turnover

22.74

Net working capital

$382.8M

Quick ratio

1.49

Working capital

$1.1B

Working capital turnover

6.18

Metric	Value
Buyback yield / dilution	-1.33%
Dividend yield	0%
Shareholder yield	-1.33%

Metric

Value

Buyback yield / dilution

-1.33%

Dividend yield

Shareholder yield

-1.33%

Metric	Value
150-day SMA	$10.26
1D price change	0.25%
1M price change	12.86%
1M total return	12.86%
1W price change	-1.86%
1W total return	-1.86%
1Y price change	-21.43%
1Y return CAGR	-21.45%
1Y total return	-21.43%
20-day SMA	$11.54
200-day SMA	$9.95
3M price change	8.63%
3M total return	8.63%
50-day SMA	$11.10
50-day SMA vs 200-day SMA	50over200
52-week high	$15.48
52-week high date	2025-10-29
52-week low	$7.71
52-week low date	2026-06-03
6M price change	18.48%
6M total return	18.48%
All-time high	$20.72
All-time high date	2024-10-16
All-time low	$7.71
All-time low date	2026-06-03
Average true range (ATR)	$0.41
Average volume	457.7K
Beta (1Y)	0.74
Beta (2Y)	0.56
Beta (5Y)	0.72
Change from 52-week high	-23.39%
Change from 52-week low	53.83%
Change from all-time high	-42.59%
Change from all-time low	54.28%
Change from open	-1.5%
Day's gap	1.78%
Dollar volume	$3.6M
High price	$12.05
Low price	$11.81
Monthly RSI	47.47
Open price	$12.04
Position in 52-week range	20.83%
Previous close	$11.83
Price vs 150-day SMA	15.89%
Price vs 20-day SMA	3.08%
Price vs 200-day SMA	19.56%
Price vs 50-day SMA	7.17%
Relative volume	0.67
Return from IPO open	-20.33%
Return from IPO price	-25.31%
RSI	57.54
Sharpe ratio	-0.22
Sortino ratio	-0.17
Volume	306.9K
Weekly RSI	61.6
YTD price change	34.71%
YTD total return	34.71%

Metric

Value

150-day SMA

$10.26

1D price change

0.25%

1M price change

12.86%

1M total return

12.86%

1W price change

-1.86%

1W total return

-1.86%

1Y price change

-21.43%

1Y return CAGR

-21.45%

1Y total return

-21.43%

20-day SMA

$11.54

200-day SMA

$9.95

3M price change

8.63%

3M total return

8.63%

50-day SMA

$11.10

50-day SMA vs 200-day SMA

50over200

52-week high

$15.48

52-week high date

2025-10-29

52-week low

$7.71

52-week low date

2026-06-03

6M price change

18.48%

6M total return

18.48%

All-time high

$20.72

All-time high date

2024-10-16

All-time low

$7.71

All-time low date

2026-06-03

Average true range (ATR)

$0.41

Average volume

457.7K

Beta (1Y)

0.74

Beta (2Y)

0.56

Beta (5Y)

0.72

Change from 52-week high

-23.39%

Change from 52-week low

53.83%

Change from all-time high

-42.59%

Change from all-time low

54.28%

Change from open

-1.5%

Day's gap

1.78%

Dollar volume

$3.6M

High price

$12.05

Low price

$11.81

Monthly RSI

47.47

Open price

$12.04

Position in 52-week range

20.83%

Previous close

$11.83

Price vs 150-day SMA

15.89%

Price vs 20-day SMA

3.08%

Price vs 200-day SMA

19.56%

Price vs 50-day SMA

7.17%

Relative volume

0.67

Return from IPO open

-20.33%

Return from IPO price

-25.31%

RSI

57.54

Sharpe ratio

-0.22

Sortino ratio

-0.17

Volume

306.9K

Weekly RSI

61.6

YTD price change

34.71%

YTD total return

34.71%

Metric	Value
Float	21.8M
Float percentage	15.43%
Shares change (QoQ)	0.9%
Shares change (YoY)	1.33%
Shares held by insiders	1.72%
Shares held by institutions	22.35%
Shares outstanding	141M
Short % of float	21.29%
Short % of shares	3.28%
Short ratio	10.6 days

Metric

Value

Float

21.8M

Float percentage

15.43%

Shares change (QoQ)

0.9%

Shares change (YoY)

1.33%

Shares held by insiders

1.72%

Shares held by institutions

22.35%

Shares outstanding

141M

Short % of float

21.29%

Short % of shares

3.28%

Short ratio

10.6 days

Ardent Health, Inc. (ARDT)

Price

Financial snapshot

Fair-value bridge

Latest news · ARDT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ARDT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ARDT

Frequently asked questions